Featuring an interview with Dr Matthew Lunning, including the following topics:
Tafasitamab for follicular lymphoma (0:00)frontMIND Phase III trial of tafasitamab/lenalidomide/R-CHOP for diffuse large B-cell lymphoma (7:51)Subscribe in seconds and receive Hematologic Oncology Update's news feed updates in your inbox, on your phone or even read them from your own news page here on follow.it.
You can select the updates using tags or topics and you can add as many websites to your feed as you like.
And the service is entirely free!
Follow Hematologic Oncology Update: Hematologic Oncology Update